TY - JOUR T1 - Dual antiplatelet therapy for acute coronary syndromes: How long to continue? JF - Cleveland Clinic Journal of Medicine JO - Cleve Clin J Med SP - 675 LP - 688 DO - 10.3949/ccjm.83a.15092 VL - 83 IS - 9 AU - Meghana Halkar AU - A. Michael Lincoff Y1 - 2016/09/01 UR - http://www.ccjm.org/content/83/9/675.abstract N2 - For patients with an acute coronary syndrome event, current guidelines recommend dual antiplatelet therapy for at least 12 months after drug-eluting stent placement. However, several clinical trials have assessed whether continuing dual antiplatelet therapy beyond 12 months is beneficial. We review the pros and cons of extending dual antiplatelet therapy. ER -